Skip to main content

Advertisement

ADVERTISEMENT

News

News
05/24/2023
“This new procedure we specifically engineered for Fred has never been done before but it replicates a bypass operation performed in the 1950s,” said Dr. O’Neill.
“This new procedure we specifically engineered for Fred has never been done before but it replicates a bypass operation performed in the 1950s,” said Dr. O’Neill.
“This new procedure we...
05/24/2023
Cath Lab Digest
News
05/23/2023
ENTRUST is a randomized, double-blind, placebo-controlled global trial that is planned to enroll up to 360 severe hypertriglyceridemia patients.
ENTRUST is a randomized, double-blind, placebo-controlled global trial that is planned to enroll up to 360 severe hypertriglyceridemia patients.
ENTRUST is a randomized,...
05/23/2023
Cath Lab Digest

Advertisement

News
05/22/2023
“When the war started, myself and others on my team decided to stay at work to do our best to help our people, soldiers, neighbors and relatives to survive. But we decided it was not enough to only maintain, but that we must develop and raise...
“When the war started, myself and others on my team decided to stay at work to do our best to help our people, soldiers, neighbors and relatives to survive. But we decided it was not enough to only maintain, but that we must develop and raise...
“When the war started, myself...
05/22/2023
Cath Lab Digest
News
05/22/2023
The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication,...
The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication,...
The MSCAI designation is awarded...
05/22/2023
Cath Lab Digest
News
05/22/2023
The $115,000 fellowship opportunity was made possible by support from Abiomed (founding supporter), Boston Scientific, Medtronic, and Shockwave Medical, Inc., and is offered to interventional cardiology (IC) fellows or practicing...
The $115,000 fellowship opportunity was made possible by support from Abiomed (founding supporter), Boston Scientific, Medtronic, and Shockwave Medical, Inc., and is offered to interventional cardiology (IC) fellows or practicing...
The $115,000 fellowship...
05/22/2023
Cath Lab Digest

Advertisement

News
05/22/2023
PHOENIX (May 20, 2023) – Today during the SCAI 2023 Scientific Sessions, thirty early-career interventional cardiologists were the inaugural recipients of a newly created award highlighting excellence in interventional cardiology....
PHOENIX (May 20, 2023) – Today during the SCAI 2023 Scientific Sessions, thirty early-career interventional cardiologists were the inaugural recipients of a newly created award highlighting excellence in interventional cardiology....
PHOENIX (May 20, 2023) – Today...
05/22/2023
Cath Lab Digest
News
05/22/2023
Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker
Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker
Abbott's AVEIR™ DR i2i™ IDE...
05/22/2023
EP Lab Digest
News
05/22/2023
SIRONA 2 is an open-label, single-arm trial of 70 European patients that met its primary endpoints for safety and accuracy with the previously reported 90-day results. The 12-month results extended both the strong safety profile.
SIRONA 2 is an open-label, single-arm trial of 70 European patients that met its primary endpoints for safety and accuracy with the previously reported 90-day results. The 12-month results extended both the strong safety profile.
SIRONA 2 is an open-label,...
05/22/2023
Cath Lab Digest

Advertisement

George Dangas, MD, PhD
News
05/22/2023
Dr. Dangas is an authoritative voice on the performance of nonsurgical cardiovascular and valve interventions using both established and novel techniques, and on preventing and dissolving endovascular thrombosis.
Dr. Dangas is an authoritative voice on the performance of nonsurgical cardiovascular and valve interventions using both established and novel techniques, and on preventing and dissolving endovascular thrombosis.
Dr. Dangas is an authoritative...
05/22/2023
Cath Lab Digest
Harmony PV
News
05/20/2023
Medtronic announced two-year results of their Harmony™ Transcatheter Pulmonary Valve (TPV) System, which treats severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT).
Medtronic announced two-year results of their Harmony™ Transcatheter Pulmonary Valve (TPV) System, which treats severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT).
Medtronic announced two-year...
05/20/2023
Cath Lab Digest

Advertisement